Simplicity Solutions LLC Buys 213 Shares of Axon Enterprise, Inc. (NASDAQ:AXON)

Simplicity Solutions LLC lifted its stake in shares of Axon Enterprise, Inc. (NASDAQ:AXON) by 15.5% during the fourth quarter, according to the company in its most recent 13F filing with the SEC. The firm owned 1,587 shares of the biotechnology company’s stock after purchasing an additional 213 shares during the quarter. Simplicity Solutions LLC’s holdings in Axon Enterprise were worth $410,000 as of its most recent SEC filing.

Other institutional investors have also added to or reduced their stakes in the company. American Century Companies Inc. lifted its stake in Axon Enterprise by 103.8% in the 1st quarter. American Century Companies Inc. now owns 6,194 shares of the biotechnology company’s stock worth $853,000 after purchasing an additional 3,155 shares in the last quarter. Private Advisor Group LLC raised its position in shares of Axon Enterprise by 40.3% in the first quarter. Private Advisor Group LLC now owns 3,458 shares of the biotechnology company’s stock worth $476,000 after buying an additional 994 shares in the last quarter. Great West Life Assurance Co. Can boosted its stake in Axon Enterprise by 12.3% during the first quarter. Great West Life Assurance Co. Can now owns 37,062 shares of the biotechnology company’s stock valued at $5,247,000 after buying an additional 4,048 shares during the period. Raymond James Trust N.A. grew its position in Axon Enterprise by 4.7% during the first quarter. Raymond James Trust N.A. now owns 3,753 shares of the biotechnology company’s stock worth $517,000 after buying an additional 168 shares in the last quarter. Finally, Dimensional Fund Advisors LP increased its stake in Axon Enterprise by 2.1% in the 1st quarter. Dimensional Fund Advisors LP now owns 236,287 shares of the biotechnology company’s stock worth $32,545,000 after acquiring an additional 4,897 shares during the last quarter. Hedge funds and other institutional investors own 79.08% of the company’s stock.

Axon Enterprise Price Performance

Shares of NASDAQ:AXON opened at $293.61 on Friday. The company has a quick ratio of 2.66, a current ratio of 3.00 and a debt-to-equity ratio of 0.42. The stock has a market cap of $22.16 billion, a PE ratio of 127.65 and a beta of 0.93. The company’s fifty day moving average is $300.87 and its 200 day moving average is $257.97. Axon Enterprise, Inc. has a 52 week low of $175.37 and a 52 week high of $329.87.

Axon Enterprise (NASDAQ:AXON) last released its quarterly earnings data on Tuesday, February 27th. The biotechnology company reported $0.77 EPS for the quarter, topping the consensus estimate of $0.48 by $0.29. The firm had revenue of $432.14 million for the quarter, compared to the consensus estimate of $418.97 million. Axon Enterprise had a return on equity of 14.11% and a net margin of 11.14%. Research analysts anticipate that Axon Enterprise, Inc. will post 2.44 earnings per share for the current year.

Analysts Set New Price Targets

A number of brokerages have recently issued reports on AXON. StockNews.com downgraded Axon Enterprise from a “buy” rating to a “hold” rating in a research report on Thursday, March 14th. Argus began coverage on shares of Axon Enterprise in a research report on Wednesday, March 13th. They set a “buy” rating and a $380.00 target price for the company. The Goldman Sachs Group increased their price target on shares of Axon Enterprise from $297.00 to $339.00 and gave the stock a “buy” rating in a report on Wednesday, February 28th. TheStreet downgraded shares of Axon Enterprise from a “b” rating to a “c+” rating in a report on Tuesday, February 27th. Finally, JPMorgan Chase & Co. increased their target price on Axon Enterprise from $330.00 to $365.00 and gave the company an “overweight” rating in a research note on Thursday, April 11th. Two investment analysts have rated the stock with a hold rating and nine have assigned a buy rating to the company’s stock. Based on data from MarketBeat.com, the company has a consensus rating of “Moderate Buy” and a consensus price target of $312.64.

Axon Enterprise Profile

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.